More effective cancer treatments, and even cures, are getting tantalizingly close on a number of fronts.
Australian researchers in the the Melbourne based trial took place over four years and tested over 100 patients. The trial showed researchers at the Royal Melbourne Hospital and Peter MacCallum Cancer Centre that the drug Venetoclax can greatly reduce cancer blood cells.
Positive results were seen in 79 percent of cases involving patients suffering from chronic lymphocytic leukemia. Patients who had previously undergone treatment were left as good as new after agreeing to the new pill trials.